ClinicalTrials.gg

Rempex Pharmaceuticals clinical trials

Acquired by Novartis, Jan 6, 2020 · source ↗

The registry lists 7 studies whose lead sponsor is Rempex Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2023.

Before and after it joined Novartis

First submitted before Rempex Pharmaceuticals became part of Novartis
7
First submitted after Rempex Pharmaceuticals became part of Novartis
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Rempex Pharmaceuticals’ studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 7 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed686%
  • Stopped early114%

Phase

  • Phase 17

Where

  • Australia3
  • United States3
  • Austria1

Over the years

  1. 212
  2. 13
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18
  8. 19
  9. 20
  10. 21
  11. 22
  12. 23
  13. 24
  14. 25
  15. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)7 studies

Something wrong with this grouping? Tell us on the Novartis page.

Studies

Recruiting first, then most recently updated. Showing 7 of 7. All Novartis studies →